| Financial Year |
March 31 2023 |
| Monetary Funds |
344,183,876.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
69,323,481.36 |
| Advances to Suppliers |
9,162,360.21 |
| Other Receivables |
6,921,139.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,175,469.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,313,106.28 |
| Total Current Assets |
613,434,102.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,628,446.87 |
| Investment Properties |
4,718,669.22 |
| Fixed Assetes |
42,913,206.23 |
| Under-construction Projects |
66,172,534.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,666,331.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
105,270.46 |
| Deferred Income Tax Assets |
76,280,839.80 |
| Other Non-Current Assets |
18,912,300.00 |
| Sub-Total of Non-Current Assets |
286,907,755.28 |
| Total Assets |
900,341,857.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,637,639.65 |
| Accounts Payable |
52,409,083.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,123,867.83 |
| Taxes Payable |
3,803,364.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,059,913.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,995,663.70 |
| Other Current Liabilities |
4,576,084.82 |
| Sub-Total of Current Liabilities |
171,157,530.04 |
| Long-term Loans |
28,987,850.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,133,646.48 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
62,430,989.97 |
| Total Liabilities |
233,588,520.01 |
| Paid-In Capital(Or Share Stock) |
160,022,492.00 |
| Capital Surplus |
743,450,431.03 |
| Surplus Reserve |
13,828,517.56 |
| LESS:Treasury Stock |
66,386,770.00 |
| Undistributed Profits |
-183,475,869.52 |
| Minority Stockholder's Interest |
560,836.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
666,192,501.02 |
| Owner's Equity（Stockholder's Equity） |
666,753,337.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
900,341,857.75 |
